March 29, 2011 – The U.S. Food and Drug Administration (FDA) cleared a wireless point-of-care testing system that allows real time transmission of diagnostic test results generated directly from the patient bedside.
March 29, 2011 – One-year outcomes from Cohort A of the PARTNER trial will be presented April 3 at the American College of Cardiology’s (ACC) 60th Annual Scientific Session and Expo in New Orleans. Additionally, economic data from Cohort B will be featured in a session immediately after.
Wide beam reconstruction (WBR) reduces both dose and image acquisition time by 50 percent for myocardial perfusion SPECT (MPI), according to a new study published in the March-April 2011 issue of the Journal of Nuclear Cardiology. WBR is a software program by UltraSPECT for reconstructing nuclear medicine images.
If you enjoy this content, please share it with a colleague
March 28, 2011- Terumo Medical Corp., a U.S.-based subsidiary of Japan-based Terumo Corp., expressed its condolences and support to its Japanese colleagues and others who are managing the extremely difficult situation resulting
March 28, 2011 – Outcomes data from a subset analysis of the global e-HEALING registry were published online in the Journal of Interventional Cardiology and demonstrated the effectiveness of a stent in diabetic patients. The Genous Stent, from OrbusNeich, showed low definite and probable stent thrombosis (ST) comparable to non-diabetics.
March 28, 2011 – The Therapeutic Goods Administration (TGA) of Australia has approved the HeartWare Ventricular Assist System for listing on the Australian Register of Therapeutic Goods (ARTG).
March 28, 2011 – Patients who have suffered a "mini stroke" are at twice the risk of heart attack than the general population, according to research reported in Stroke: Journal of the American Heart Association.
March 28, 2011 – The U.S. Food and Drug Administration (FDA) has approved two new cardiac resynchronization therapy-pacemaker (CRT-P) systems. The Consulta and Syncra CRT-P systems, from Medtronic, are the first to include OptiVol Fluid Status Monitoring. The feature identifies patients at risk for worsening heart failure before symptoms develop.
March 28, 2011 – The Society of Nuclear Medicine’s (SNM) 2011 Annual Meeting, June 4-8 in San Antonio, offers a variety of new education options to nuclear medicine and molecular imaging professionals. With new topics, formats and technologies, the meeting provides a comprehensive review of the latest research and issues in the field.
Horizon Cardiology, a cardiovascular information system (CVIS) from McKesson, is a comprehensive information solution from fetal to adult (including congenital) that supports cardiac and peripheral catheterization, hemodynamic monitoring, echocardiography, vascular ultrasound, nuclear cardiology and electrocardiogram (ECG) management.